<DOC>
	<DOCNO>NCT02969928</DOCNO>
	<brief_summary>The aim study assess clinical outcome full-mouth ultrasonic debridement combine clarithromycin amoxicillin + metronidazole association treatment generalize aggressive periodontitis ( GAgP ) .</brief_summary>
	<brief_title>Two Different Antibiotic Agents Treat Generalized Aggressive Periodontitis</brief_title>
	<detailed_description>The study methodology accord CONSORT-STATEMENT 2010 randomize control clinical trial . Study Design The study design prospective , interventional , parallel , triple blind , randomize , control clinical trial aim assess clinical outcome full-mouth ultrasonic debridement combine clarithromycin amoxicillin + metronidazole association treatment generalize aggressive periodontitis ( GAgP ) . The study approve Institute Science Technology 's ( ICT - State University São Paulo ) Ethics Committee ( protocol 1.079.307 ) . Source data The population study recruit among patient refer Science Technology Institute - ICT- São José do Campos , College Dentistry . Patients fill healthy history questionnaire ensure medically qualified participate study . Based power calculation study , 44 subject divide two group need achieve 80 % power detect 0.8 mm difference clinical attachment level ( CAL ) patient . Clinical Parameters All clinical parameter assess single blind , train calibrated examiner ( CFA ) periodontal therapy ( baseline ) 3 6 month use manual probe . Measurements do six site per tooth ( mesiobuccal , buccal , disto-buccal , distolingual , lingual , mesiolingual ) teeth , except third molar . The following clinical parameter evaluate : 1 ) Full-mouth plaque index ( FMPI ) ; 2 ) Bleeding probe ( BoP ) ; 3 ) Probing depth ( PD ) : distance bottom sulcus/pocket gingival margin ; 4 ) Gingival recession ( GM ) : distance free gingival margin cement-enamel junction ( CEJ ) ; 5 ) Clinical attachment level ( CAL ) : distance bottom sulcus/pocket CEJ . The CEJ identify careful probe cervical area . Calibration Randomization Initially , total ten patient present GAgP select . The designated examiner ( CFA ) measure CAL PD patient twice within 24 hour , interval ≥ 1 hour examination . Then , measure submit intraclass correlation test examiner judge calibrate reach 90 % agreement . Patients allocate two group accord computer-generated list . The allocation implement investigator ( NCCS ) directly involve examination treatment procedure . All medication prepare encased identical opaque cod bottle manipulation pharmacy São José do Campos/São Paulo . Treatment Protocols All patient treat periodontal therapy one-stage , full mouth , ultrasonic debridement ( FMUD ) . In single session , patient receive local anesthesia periodontal debridement ultrasound equipment ( Cavitron - Dentsply EUA ) subgingival tip ( UI25KSF10S , Hu-Friedy ) . All diseased site instrument one session . The debridement session perform single experienced train periodontist ( MPS ) , different examiner . Immediately mechanical therapy , patient allocate one two treatment protocol : 1 . Clarithromycin ( CLM ) group ( n = 22 ) : FMUD + CLM 500 mg bid , 7 day 2 . Amoxicillin ( AMX ) + metronidazole ( MET ) group ( n = 22 ) : FMUD + ( AMX 500 mg tid + MET 400 mg tid , 7 day . All patient start take pill immediately FMUD session . Compliance Adverse Effects After 7 day periodontal treatment , patient ask return medication take and/or empty bottle . The number pill take subject document . Moreover , patient instruct return self-report form fill possible adverse effect order help evaluate adherence systemic antimicrobial regimen . Statistical analysis Mean standard deviation calculate parameter . The normal distribution data analyze Shapiro-Wilk test . Data clinical measurement subject analysis variance ( repeated measure ) inter intra-group comparison .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Aggression</mesh_term>
	<mesh_term>Aggressive Periodontitis</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>1. diagnosis GAgP ( AAP , 1999 ) ; 2. presence ≥20 teeth ; 3. presence ≥ 6 site present PD ≥ 5mm bleed probing ( BOP ) ≥2 site PD ≥7mm ( include incisor first molar , addition two noncontiguous teeth ) ; 4. good general health ; 5 . ≤ 35 year old ; 6. agree participate study sign write informed consent . All subject individually inform objective , probable risk benefit protocol treatment ( accord Resolution nº196 October 1996 Professional Code Dental Ethics 179/93 ) . 1. pregnancy lactating ; 2. suffer systemic disease ( e.g . cardiovascular disorder , diabetes , blood dyscrasia , immunodeficiency , etc ) could alter course periodontal disease ; 3. take antimicrobial previous 6 month ; 4. take longterm antiinflammatory drug ; 5. previous periodontal treatment within last 12 month ; 6. smoker .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Full-mouth ultrasonic debridement</keyword>
	<keyword>Clarithromycin</keyword>
	<keyword>Amoxicillin</keyword>
	<keyword>Metronidazole</keyword>
</DOC>